FDA Clears AI-Powered Algorithm for Earlier Detection of Hypertrophic Cardiomyopathy
Last week, the FDA authorized marketing for Viz.AI’s Viz HCM, a standalone ECG analysis software to identify adult patients for further follow-up for hypertrophic cardiomyopathy.
Source: hcplive.com